Skip to main content

Table 3 Univariate Cox analysis of dyspnea in patients with tuberculous lung damage

From: Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment

Variables

Follow-up time Person-years

Incidence rate, per 10 person-years

Total (n, %)

mMRC = 0 (n = 45, %)

mMRC ≥ 1 (n = 27, %)

HR (95%CI)

P value

Sex

       

  Male

92.5

1.1

28 (38.9)

18 (64.3)

10 (35.7)

Ref

 

  Female

166.4

1.0

44 (61.1)

27 (61.4)

17 (38.6)

0.787 (0.358–1.729)

0.551

Age group (years)

       

  < 60

242.4

1.0

67 (93.1)

43 (64.2)

24 (35.8)

Ref

 

  ≥ 60

16.5

1.8

5 (6.9)

2 (40.0)

3 (60.0)

0.826 (0.240–2.845)

0.762

BMI (kg/m2)

       

  < 18.5)

38.4

1.3

12 (16.7)

7 (58.3)

5 (41.7)

Ref

 

  18.5–24.9

191.0

1.0

52 (72.2)

33 (63.5)

19 (36.5)

0.630 (0.234–1.694)

0.360

  ≥ 25

29.5

1.0

8 (11.1)

5 (62.5)

3 (37.5)

0.397 (0.093–1.693)

0.212

Smoking history

       

  No

230.2

1.1

62 (86.1)

37 (59.7)

25 (40.3)

Ref

 

  Yes

28.7

0.7

10 (13.9)

8 (80.0)

2 (20.0)

0.712 (0.168–3.016)

0.645

Comorbiditiesa

       

  No

209.8

1.1

57 (79.2)

34 (59.6)

23 (40.4)

Ref

 

  Yes

49.1

0.8

15 (20.8)

11 (73.3)

4 (26.7)

1.313 (0.443–3.890)

0.623

mMRC

       

  0

80.1

1.2

20 (27.8)

10 (50.0)

10 (50.0)

Ref

 

  ≥ 1

178.8

1.0

52 (72.2)

35 (67.3)

17 (32.7)

0.486 (0.170–1.389)

0.178

Site of TDL

       

  Left lung

203.9

0.9

56 (77.8)

37 (63.2)

19 (32.8)

Ref

 

  Right lung

55.0

1.5

16 (22.2)

8 (50.0)

8 (50.0)

1.874 (0.817–0.296)

0.138

Combined with other pathogenic bacteria

       

  No

183.5

1.0

50 (69.4)

31 (62.0)

19 (38.0)

Ref

 

  CPA or NTM

75.4

1.1

22 (30.6)

14 (63.6)

8 (36.4)

1.263 (0.550–2.899)

0.583

Chest CT

       

Number of contralateral lesions

       

  < 2

158.2

1.1

42 (58.3)

25 (59.5)

17 (40.5)

Ref

 

  ≥ 2

100.7

1.0

30 (41.7)

20 (66.7)

10 (33.3)

1.132 (0.506–2.534)

0.762

  Spinal

       

Cobb angles ≤ 5°

156.7

0.6

40 (55.6)

30 (75)

10 (25)

Ref

 

Cobb angles > 5°

102.2

1.7

32 (44.4)

15 (46.9)

17 (53.1)

4.628 (1.953–10.964)

 < 0.01

Lung function

       

  FVC, L

2.4 ± 0.7

2.2 ± 0.6

0.621 (0.245–1.570)

0.314

  FVC%

       

  ≥ 80% pred

39.6

0.5

11 (15.3)

9 (81.8)

2 (18.2)

Ref

 

  < 80% pred

219.3

1.1

61 (84.7)

36 (59.0)

25 (41.0)

2.183 (0.501–9.506)

0.298

  FEV1, L

1.9 ± 0.6

1.7 ± 0.5

0.457 (0.157–1.332)

0.151

  FEV1/FVC, %

78.1 ± 11.6

74.1 ± 11.6

0.970 (0.922–1.020)

0.233

  DLCO, L

6.0 (4.8,6.9)

5.1 (4.3,7.2)

0.869 (0.646–1.168)

0.352

  DLCO%

       

  ≥ 80%pred

163.3

0.4

44 (61.1)

37 (84.1)

7 (15.9)

Ref

 

  < 80%pred

95.6

2.1

28 (38.9)

8 (28.6)

20 (71.4)

2.794(1.168–6.683)

0.021

Albumin, g/L

39.4 ± 7.7

37.5 ± 5.2

0.957 (0.887–1.033)

0.257

Albumin

       

  Normal

203.7

1.0

54 (75.0)

34 (63.0)

20 (37.0)

Ref

 

  Decreased

55.2

1.3

18 (25.0)

11 (61.1)

7 (38.9)

1.557 (0.654–3.706)

0.317

Hemoglobin, g/L

119.4 ± 20.7

122.3 ± 18.4

1.008 (0.983–1.033)

0.541

Hemoglobin

       

  Normal

240.5

1.1

67 (93.1)

41 (61.2)

26 (38.8)

Ref

 

  Anemia

18.4

0.5

5 (6.9)

4 (80.0)

1 (20.0)

0.733 (0.097–5.560)

0.764

Blood glucoseb

       

  PaO2, Torr

98.3 (88.6,111)

95.0 (86.7,111.8)

0.994 (0.979–1.009)

0.405

  PaO2

       

  Normal

175.7

0.9

50 (92.6)

35 (70.0)

15 (30.0)

Ref

 

  Decreased

16.9

1.2

4 (7.4)

2 (50.0)

2 (50.0)

1.607 (0.357–7.236)

0.537

  PaCO2, Torr

42.0 (40.0,45.3)

43.4 (40.6,46.3)

1.088 (0.926–1.277)

0.305

  PaCO2

       

  Normal

137.1

0.8

39 (72.2)

28 (71.8)

11 (28.2)

Ref

 

  Decreased

55.5

1.1

15 (27.8)

9 (60.0)

6 (40.0)

1.157 (0.424–3.153)

0.776

Surgical excision range

       

  Lobectomy of lungs

89.9

1.1

25 (34.7)

15 (60.0)

10 (40.0)

Ref

 

  Pneumonectomy with or without pleura

169.0

1.0

47 (65.3)

30 (63.8)

17 (36.2)

0.657 (0.297–1.454)

0.300

  1. BMI Body mass index; CPA Chronic pulmonary aspergillosis; FVC% Forced vital capacity of predicted; DLCO% Lung diffusion capacity of predicted; HR Hazard ratio
  2. a: Comorbidities including hypertension diabetes and coronary heart disease; b: Preoperative arterial blood gas analysis was performed in 54 patients